… (AR) may play a role in prostate cancer etiology. This study focuses on the inhibitory effects
of resveratrol on androgen action in the LNCaP prostate cancer cell line. We found that …

… the human prostate cancer cell line LNCaP to study gene expression differences during
prostate cancer progression to androgen-independent disease. Production of prostate-specific …

… Cell Culture and Reagent Treatment Conditions LNCaP human prostatic carcinoma cells
were grown in RPMI 1640 cell culture medium supplemented with 10% fetal bovine serum, 1% …

… hormone-refractory prostate cancer. To investigate … prostate cancer, we established a useful
LNCaP cell model that resembles the clinical scenario of hormone-refractory prostate cancer…

… We inhibited AR expression in LNCaP prostate tumor cells by … as a therapy for advanced
prostate cancer. Among the various AR … Treatment of LNCaP cells with as750/15 reduced AR …

… Using a human prostatic cancer cell line, LNCaP, we also demonstrated organ-specificity
in the induction of human prostatic tumor growth in athymic mice (Gleave et al., 1991, 1992); …

… an androgen-responsive LNCaP prostate cancer cell line. Western … LNCaP cells express the
AR and a number of androgen-inducible … and function of AR in LNCaP prostate cancer cells. …

… mGluR8 was silenced by DHT treatment in LNCaP cells. These data suggest that these
components of the Glu system are hormonally regulated in human LNCaP prostate cancer cells. …

… In the present paper we report that the growth of LNCaP human prostatic epithelial cancer
cells is significantly stimulated by physiological concentrations of both E, and DHT as well as …

… prostate cancer. We have established an androgen-independent prostatic carcinoma LNCaP-AI
(defined as a LNCaP cell … from the androgen-dependent LNCaP-FGC cells. In contrast to …